Skip to content

Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)

Evaluation of Stepped Care for Chronic Pain in Iraqi/Afghanistan Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00386243
Acronym
ESCAPE
Enrollment
242
Registered
2006-10-11
Start date
2007-12-31
Completion date
2012-09-30
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Pain, Pain, Intractable

Keywords

analgesia, analgesics, cognitive behavioral therapy, Pain, self-management, stepped care, musculoskeletal pain

Brief summary

The purpose of this study is to determine if a stepped-care intervention makes pain symptoms better and reduces activity limitations because of pain. Our two primary hypotheses are that in OIF/OEF veterans with chronic pain: 1. Stepped care is more effective than usual care in reducing pain-related disability 2. Stepped care is more effective than usual care in reducing psychological distress

Detailed description

Through the Evaluation of Stepped Care for Chronic Pain (ESCAPE) trial we aim to develop and test a stepped-care intervention to improve functional and work-related outcomes in Operation Iraqi Freedom/Operation Enduring Freedom veterans with chronic musculoskeletal pain. Stepped-care involves starting with lower intensity, less costly treatments initially (Step 1) and stepping up to more intensive, costly, or complex treatments in patients with inadequate response (Step 2). The study design will be a randomized controlled trial. The stepped care approach will involve 12 weeks of a pain self-management program in Step 1 followed by 12 weeks of brief cognitive behavioral therapy in participants with inadequate improvement in pain-related disability (Step 2). Patients treated in usual care will be the control group. Thus, the primary objective of the ESCAPE trial is to conduct a randomized controlled trial to compare the effectiveness of a stepped care intervention vs. usual care in OIF/OEF veterans with chronic and disabling musculoskeletal pain and evaluate the impact of this intervention on pain-related disability, work function, psychological distress, and secondary outcomes.

Interventions

BEHAVIORALCognitive behavioral therapy

Cognitive behavioral therapy is delivered by phone by a nurse care-manager 6 times over a 12-week period. Sessions last approximately 45 minutes and occur at weeks 14, 16, 18, 20, 22, and 24 of the study.

The pain self-management program is delivered by a nurse care-manager during a 12-week period. Sessions are each 45 minutes long and phone-based. They occur at baseline, week 1, week 3, week 6, week 9, and week 12.

DRUGCo-Analgesic Therapy

Amitriptyline, start at 10-25, titrate to 100 mg Nortriptyline, start at 10-25, titrate to 100 mg Gabapentin, titrate up to 900-1200 tid venlafaxine, carbemazepine, duloxetine, and/or pregabalin Cyclobenzaprine, titrate to 10 mg TID fluoxetine, sertraline, citalopram

Tramadol 50 mg BID or TID and titrate to 100 mg QID Acetaminophen/codeine (300mg/30mg). Take 1 or 2 tablets qid prn pain Acetaminophen/hydrocodone (500mg/5mg). Take 1 or 2 tablets qid prn pain Acetaminophen/oxycodone (500mg/5mg). Take 1 or 2 tablets qid prn pain Morphine SR (30mg). Start at 30 mg twice a day (titrate up to 240mg/day if needed) Methadone (5-10mg). Start at 5mg bid; titrate 10mg tid (max 20mg tid)

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have musculoskeletal pain of the low back, cervical spine, or extremities * have chronic pain (\>3 months duration) * have moderate functional impairment * have access to a working telephone * Indianapolis Roudebush VA Medical Center patient or Walter Reed Army Medical Center patient * willing to travel at least once to study site

Exclusion criteria

* prior back or cervical spine surgery or surgery pending * active psychosis * incompetent for interview * severe impairment of hearing or speech * active suicidal ideation * current alcohol or other substance dependence or abuse

Design outcomes

Primary

MeasureTime frameDescription
Roland-Morris Disability Questionnaireat baseline and 9 monthsThis is a 24-item pain specific disability questionnaire consisting of 24 questions which are related specifically to physical functions that are likely to be affected by back pain. The questionnaire is scored by adding up the number of items checked by the subject (0-24 range). Greater levels of disability are reflected by higher numbers.
Brief Pain Inventory (Interference)Baseline and 9 monthsThis is an 7-item measure that provides scores for pain-related functional impairment. The seven (7) pain interference items are rated on a simple numeric rating scale from 0-10. On the scale 0 represents no interference and 10 is completely interferes. The pain interference score is achieved by taking the total of all seven (7) scores and dividing it by the number of items (7).

Secondary

MeasureTime frameDescription
SF-Mental Component Summary (MCS)Baseline and 9 monthsThis scale provides a measure of mental health quality of life. It is measure on a 0 to 100 scale with higher scores representing better mental health
PHQ-9 DepressionBaseline and 9 monthsThis measure assesses depression symptoms on a 0 to 27 scale with higher scores representing more severe depression
PTSD Checklist-17 Civilian Version (PCL-C)Baseline and 9 monthsThe PCL-17 is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Two versions of the PCL exist: PCL-Military and PCL-Civilian.We used the PCL-Civilian version because it addresses the broadest range of possible events as the traumatic stressor. The PCL-C has demonstrated strong reliability and validity in multiple samples. A total symptom severity score (range = 17-85) can be obtained by summing the scores from each of the 17 items that have response options ranging from 1 Not at all to 5 Extremely. Higher scores represent more severe PTSD symptoms.
GAD-7 Anxiety ScoreBaseline and 9 monthsThis 7-item scale assesses anxiety symptoms on a 0 to 21 scale with higher scores representing more severe anxiety symptoms
Pain Catastrophizing Scale (PCS)Baseline and 9 monthsThe PCS total score is computed by summing responses to all 13 items. PCS total scores range from 0-52 with higher scores representing more pain catastrophizing.

Countries

United States

Participant flow

Recruitment details

Enrollment began December 2007 and concluded June 2011. The final assessment was completed by May 2012. All subjects were recruited from the Roudebush VA Medical Center.

Participants by arm

ArmCount
Usual Care
Study subjects randomized to this arm would receive usual care from their provider(s). No study intervention is undertaken on subjects in this arm. Participants in Usual Care would complete the same four outcome assessments (surveys) throughout the course of the study that members of the intervention complete.
121
Stepped Care
Study subjects randomized to this arm would receive stepped care for their pain. Stepped care involves FDA-approved analgesic therapy, a 12-week pain self-management program, and if pain does not improve, a 12-week cognitive behavioral therapy program. Pain self-management program : The pain self-management program is delivered by a nurse care-manager during a 12-week period. Sessions are each 45 minutes long and phone-based. They occur at baseline, week 1, week 3, week 6, week 9, and week 12. Cognitive behavioral therapy : Cognitive behavioral therapy is delivered by phone by a nurse care-manager 6 times over a 12-week period. Sessions last approximately 45 minutes and occur at weeks 14, 16, 18, 20, 22, and 24 of the study. Co-Analgesic Therapy
121
Total242

Baseline characteristics

CharacteristicStepped CareUsual CareTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
120 Participants121 Participants241 Participants
Age, Continuous36.4 years
STANDARD_DEVIATION 10.1
38.2 years
STANDARD_DEVIATION 10.5
36.7 years
STANDARD_DEVIATION 10.3
Region of Enrollment
United States
121 participants121 participants242 participants
Sex: Female, Male
Female
12 Participants16 Participants28 Participants
Sex: Female, Male
Male
109 Participants105 Participants214 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1214 / 121
serious
Total, serious adverse events
1 / 1216 / 121

Outcome results

Primary

Brief Pain Inventory (Interference)

This is an 7-item measure that provides scores for pain-related functional impairment. The seven (7) pain interference items are rated on a simple numeric rating scale from 0-10. On the scale 0 represents no interference and 10 is completely interferes. The pain interference score is achieved by taking the total of all seven (7) scores and dividing it by the number of items (7).

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CareBrief Pain Inventory (Interference)At Baseline5.4 units on a scaleStandard Deviation 2.4
Usual CareBrief Pain Inventory (Interference)At 9 months4.5 units on a scaleStandard Deviation 2.7
Stepped CareBrief Pain Inventory (Interference)At Baseline5.3 units on a scaleStandard Deviation 2.1
Stepped CareBrief Pain Inventory (Interference)At 9 months3.8 units on a scaleStandard Deviation 2.6
Primary

Roland-Morris Disability Questionnaire

This is a 24-item pain specific disability questionnaire consisting of 24 questions which are related specifically to physical functions that are likely to be affected by back pain. The questionnaire is scored by adding up the number of items checked by the subject (0-24 range). Greater levels of disability are reflected by higher numbers.

Time frame: at baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CareRoland-Morris Disability Questionnaire9 months12.1 scores on a scaleStandard Deviation 6.4
Usual CareRoland-Morris Disability Questionnairebaseline13.7 scores on a scaleStandard Deviation 4.7
Stepped CareRoland-Morris Disability Questionnairebaseline14.0 scores on a scaleStandard Deviation 4.3
Stepped CareRoland-Morris Disability Questionnaire9 months10.6 scores on a scaleStandard Deviation 6.3
Secondary

GAD-7 Anxiety Score

This 7-item scale assesses anxiety symptoms on a 0 to 21 scale with higher scores representing more severe anxiety symptoms

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CareGAD-7 Anxiety ScoreBaseline8.66 units on a scaleStandard Deviation 5.22
Usual CareGAD-7 Anxiety Score9 months7.85 units on a scaleStandard Deviation 5.5
Stepped CareGAD-7 Anxiety ScoreBaseline8.95 units on a scaleStandard Deviation 5.3
Stepped CareGAD-7 Anxiety Score9 months7.89 units on a scaleStandard Deviation 5.55
Secondary

Pain Catastrophizing Scale (PCS)

The PCS total score is computed by summing responses to all 13 items. PCS total scores range from 0-52 with higher scores representing more pain catastrophizing.

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CarePain Catastrophizing Scale (PCS)9 months18.40 units on a scaleStandard Deviation 13.46
Usual CarePain Catastrophizing Scale (PCS)Baseline21.81 units on a scaleStandard Deviation 12.38
Stepped CarePain Catastrophizing Scale (PCS)9 months16.63 units on a scaleStandard Deviation 12.29
Stepped CarePain Catastrophizing Scale (PCS)Baseline21.44 units on a scaleStandard Deviation 12.26
Secondary

PHQ-9 Depression

This measure assesses depression symptoms on a 0 to 27 scale with higher scores representing more severe depression

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CarePHQ-9 DepressionBaseline11.3 scores on a scaleStandard Deviation 5.64
Usual CarePHQ-9 Depression9 months10.0 scores on a scaleStandard Deviation 6.34
Stepped CarePHQ-9 DepressionBaseline11.05 scores on a scaleStandard Deviation 6.18
Stepped CarePHQ-9 Depression9 months9.45 scores on a scaleStandard Deviation 6.84
Secondary

PTSD Checklist-17 Civilian Version (PCL-C)

The PCL-17 is a standardized self-report rating scale for PTSD comprising 17 items that correspond to the key symptoms of PTSD. Two versions of the PCL exist: PCL-Military and PCL-Civilian.We used the PCL-Civilian version because it addresses the broadest range of possible events as the traumatic stressor. The PCL-C has demonstrated strong reliability and validity in multiple samples. A total symptom severity score (range = 17-85) can be obtained by summing the scores from each of the 17 items that have response options ranging from 1 Not at all to 5 Extremely. Higher scores represent more severe PTSD symptoms.

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CarePTSD Checklist-17 Civilian Version (PCL-C)Baseline25.15 score on a scaleStandard Deviation 19.74
Usual CarePTSD Checklist-17 Civilian Version (PCL-C)9 months22.71 score on a scaleStandard Deviation 19.15
Stepped CarePTSD Checklist-17 Civilian Version (PCL-C)Baseline27.62 score on a scaleStandard Deviation 19.24
Stepped CarePTSD Checklist-17 Civilian Version (PCL-C)9 months24.28 score on a scaleStandard Deviation 19.07
Secondary

SF-Mental Component Summary (MCS)

This scale provides a measure of mental health quality of life. It is measure on a 0 to 100 scale with higher scores representing better mental health

Time frame: Baseline and 9 months

Population: We had baseline data available for 241 participants; 120 in the usual care arm and 121 in the stepped care arm. At 9 months, 7 participants withdrew from the study leaving 114 usual care participants available for analysis. In the stepped care arm, 13 participants withdrew leaving 108 available for analysis

ArmMeasureGroupValue (MEAN)Dispersion
Usual CareSF-Mental Component Summary (MCS)Baseline41.4 units on a scaleStandard Deviation 13.2
Usual CareSF-Mental Component Summary (MCS)9 months42.4 units on a scaleStandard Deviation 12.5
Stepped CareSF-Mental Component Summary (MCS)Baseline41.9 units on a scaleStandard Deviation 12.1
Stepped CareSF-Mental Component Summary (MCS)9 months42.2 units on a scaleStandard Deviation 13.1

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026